Alprostadil/Prazosin Hydrochloride

前列地尔/盐酸哌唑嗪

Report date: 2022/03/15 13:52:44

Base Information

Drug NameAlprostadil/Prazosin Hydrochloride
Drug Alias Name前列地尔+哌唑嗪alprostadil/prazosinalprostadil + prazosin盐酸哌唑嗪/前列地尔Prazosin Hydrochloride+Alprostadil +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonistsProstaglandin agonists
TargetsProstaglandinAdrenergic receptors
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AlprostadilPrazosin Hydrochloride
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVivus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivus Inc
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A